Drugmakers fare well in first half

Published: 2013-08-20 07:00:00

Updated: 2013-08-20 07:00:00

Local pharmaceutical firms posted sound sales and earnings in the first half of this year on the back of solid demand, data showed Monday, while they suffered some setbacks due to the government-mandated price cuts of drugs in April of last year.

According to the data compiled by Yakup.com, a ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK